HARMONY Co-Lead Pam Bacon of Celgene kicked off the meeting showcasing HARMONY as excellent example of creating innovations in hematology by means of BigData analaytics. Celgene is a HARMONY Partner.
Big data analytics is the process of examining large data sets containing a variety of data types to uncover hidden patterns, unknown correlations, market trends, customer preferences and other useful business information. The analytical findings can lead to more effective marketing, new revenue opportunities, better customer service, improved operational efficiency, competitive advantages over rival organizations and other business or personal benefits. The goal of the Celgene event was to cast our eyes to the past, look at today and gaze into the future to share an overview of important elements of Big Data from different perspectives and its potential use and impact.
Celgene factilitated the BigData event for the Healthcare Businesswomen's Association. The HBA's purpose is to further the advancement and impact of women in the business of healthcare
Receive the latest news. Click here to subscribe!
Public-private partnership for Big Data in Hematology
HARMONY and HARMONY PLUS are funded through the Innovative Medicines Initiative (IMI), Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients. Funding is received from the IMI 2 Joint Undertaking and is listed under grant agreement for HARMONY No. 116026 and grant agreement for HARMONY PLUS No. 945406. This Joint Undertaking receives support from the European Union’s Horizon 2020 Research and Innovation Programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA).
HARMONY Coordination Office
Institute of Biomedical Research of
Salamanca (IBSAL)
Salamanca, Spain
HARMONY Communications
European Hematology Association (EHA)
The Hague, The Netherlands
